As shown in our results, these genes, especially FARSB, could activate Cell Cycle, DNA Damage Response, Hormone AR pathways, TSC/mTOR and inhibit EMT, Hormone ER, PI3K/AKT, RAS/MAPK, RTK pathways to play a regulatory role in the cancer process (Figure 12A). This evidence concerns the gene FARSB and cancer.